<DOC>
	<DOC>NCT01354977</DOC>
	<brief_summary>The purpose of this research is to study the effects of a medication called resveratrol on the body's response to insulin (a hormone to control blood sugar), on inflammation and/or on specific cells and processes in fat tissue, and on skeletal muscle metabolism and on brain function.</brief_summary>
	<brief_title>Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>BMI: 2635 Nonsmoker Normal screening labs (CMC, chemistry, LFTs PT/PTT) No CAD Good IV access High cholesterol &lt;4 week history of participation in another drug trial Severe hypertension Heart disease Liver disease of liver abnormalities Cerebrovascular disease, i.e. stroke CVD Seizures Bleeding disorders Muscle disease Cancer HIV Hepatitis (all types) Mentally disabled persons Pregnant women Allergies to Novocaine, Lidocaine, Benzocaine Subjects on the following medications: Anticoagulant and antiplatelet drugs Antiepileptic drugs Mexiletene Quinidine Cyclosporine Tacrolimus HIV protease inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Diabetes Mellitus, Type 2</keyword>
	<keyword>Glucose Metabolism Disorders</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Endocrin System Diseases</keyword>
	<keyword>Resveratrol</keyword>
	<keyword>Therapeutic Uses</keyword>
</DOC>